Skip to main content
. 2013 Oct;23(5):579–587.

Table 3.

Mortality rates according to the disease/treatment characteristics in neonatal period

Characteristic Alive (n = 400) Dead (n = 164) OR 95%CI p-Value
Respiratory distress syndrome Yes 252 (62.2%) 153 (37.8%) 8.17 4.29-15.56 <0.001
No 148 (93.1%) 11 (6.9%)
Surfactant therapy Yes 229 (62.6%) 137 (37.4%) 3.79 2.4-5.99 <0.001
No 171 (86.4%) 27 (13.6%)
Intubation-Surfactant-Extubation Yes 123 (85.4%) 21 (14.6%) 0.33 0.2-0.55 <0.001
No 277 (66%) 143 (34%)
Nasal continuous positive airway pressure Yes 166 (76.5%) 51 (23.5%) 0.64 0.43-0.94 0.02
No 234 (67.4%) 113 (32.6%)
Mechanical ventilation Yes 19 (50%) 19 (50%) 2.63 1.35-5.1 0.004
No 381 (72.4%) 145 (27.6%)
Mechanical Ventilation + Surfactant Yes 134 (50.2%) 133 (49.8%) 8.52 5.47-13.26 <0.001
No 266 (89.6%) 31 (10.4%)
Patent Ductus Arteriosus Yes 131 (71.6%) 52 (28.4%) 0.95 0.65-1.41 0.81
No 269 (70.6%) 112 (29.4%)
Necrotizing enterocolitis ≥2 Yes 3 (50%) 3 (50%) 2.47 0.49-12.35 0.27
No 397 (71.1%) 161 (28.9%)
Intra-ventricular hemorrhage (All Grade) Yes 139 (73.5%) 50 (26.5%) 2.78 1.24-6.24 0.01
No 261 (69.6%) 114 (30.4%)
Periventricular leukomalacia Yes 4 (57.1%) 3 (42.9%) 1.84 0.41-8.33 0.43
No 396 (71.1%) 161 (28.9%)
Pneumothorax Yes 20 (35.1%) 37 (64.9%) 5.54 3.1-9.89 <0.001
No 380 (75%) 127 (25%)
Pulmonary hemorrhage Yes 16 (17.4%) 76 (82.6%) 20.73 11.53-37.27 <0.001
No 384 (81.4%) 88 (18.6%)
Chronic Lung Disease Yes 84 (81.6%) 19 (18.4%) 0.49 0.29-0.84 0.01
No 316 (68.5%) 145 (31.5%)
Renal failure Yes 42 (47.7%) 46 (52.3%) 3.32 2.08-5.3 <0.001
No 358 (75.2%) 118 (24.8%)
Seizure Yes 36 (37.9%) 59 (62.1%) 5.68 3.56-9.07 <0.001
No 364 (77.6%) 105 (22.4%)
Gastrointestinal bleeding Yes 11 (29.7%) 26 (70.3%) 6.66 3.21-13.84 <0.001
No 389 (73.8%) 138 (26.2%)
Apnea Yes 155 (73.5%) 56 (26.5%) 0.82 0.56-1.2 0.31
No 245 (69.4%) 108 (30.6%)
Infection (Pneumonia +/- Meningitis +/- Sepsis) Yes 106 (71.1%) 43 (28.9%) 0.99 0.65-1.49 0.95
No 294 (70.8%) 121 (29.2%)
Anemia Yes 211 (82.7%) 44 (17.3%) 0.33 0.22-0.49 <0.001
No 189 (61.2%) 120 (38.8%)
Hematologic complication Yes 232 (75.8%) 74 (24.2%) 0.6 0.41-0.86 0.006
No 168 (65.1%) 90 (34.9%)
Metabolic complication Yes 258 (66.3%) 131 (33.7%) 2.18 1.42-3.37 <0.001
No 142 (81.1%) 33 (18.9%)
Surgical operation Yes 9 (69.2%) 4 (30.8%) 1.09 0.33-3.58 0.89
No 391 (71%) 160 (29%)

CI: Confidence Interval